US Stock MarketDetailed Quotes

INZY Inozyme Pharma

Watchlist
  • 2.990
  • +0.180+6.41%
Close Dec 20 16:00 ET
  • 3.050
  • +0.060+2.01%
Post 20:01 ET
192.08MMarket Cap-1.93P/E (TTM)

About Inozyme Pharma Company

Inozyme Pharma, Inc. is a clinical-stage rare disease biopharmaceutical company. It engages in the business of developing novel therapeutics for the treatment of diseases impacting the vasculature, soft tissue, and skeleton. The company was founded by Axel Bolte, Joseph P. Schlessinger, and Demetrios T. Braddock in September 2015 and is headquartered in Boston, MA.

Company Profile

SymbolINZY
Company NameInozyme Pharma
Listing DateJul 24, 2020
Issue Price16.00
Founded2015
CEODr. Douglas A. Treco, PhD
MarketNASDAQ
Employees59
Fiscal Year Ends12-31
Address321 Summer Street,Suite 400
CityBoston
ProvinceMassachusetts
CountryUnited States of America
Zip Code02210
Phone1-857-330-4340
Websitehttp://www.inozyme.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Douglas A. Treco, PhD
  • Chairman of the Board and Chief Executive Officer
  • 5.30M
  • Sanjay Subramanian
  • Chief Financial Officer, Principal Accounting Officer and Corporate Secretary
  • 1.03M
  • Matthew Winton
  • Chief Operations Officer
  • 1.55M
  • Axel Bolte
  • Director
  • 1.80M
  • Erik Harris
  • Director
  • --
  • Reinaldo M. Diaz
  • Lead Independent Director
  • 130.27K
  • Dr. Robert Hopfner, M.B.A.,PhD,R.Ph.
  • Independent Director
  • 112.15K
  • Lynne Sullivan
  • Independent Director
  • 122.15K
  • Dr. Sarah Bhagat, PhD
  • Independent Director
  • 114.65K
  • Dr. Martin William Edwards, M.D.
  • Independent Director
  • 129.65K
  • Edward T. Mathers
  • Independent Director
  • 116.15K
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
MicroStrategy
MSTR
+11.56%
Adobe
ADBE
+2.24%
Salesforce
CRM
+2.21%
Apple
AAPL
+1.88%
Meritage Homes
MTH
+1.78%

Unlock the Full List